CGIX - Cancer Genetics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1011
Avg. Estimate-0.160-0.77-0.3
Low Estimate-0.160-0.77-0.3
High Estimate-0.160-0.77-0.3
Year Ago EPS-0.36-0.16-1.01-0.77
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate6.3M10.77M26.94M46.82M
Low Estimate6.3M10.77M26.94M46.82M
High Estimate6.3M10.77M26.94M46.82M
Year Ago Sales7.52M7.67M29.12M26.94M
Sales Growth (year/est)-16.30%40.50%-7.50%73.80%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.11-0.13-0.16-0.17
EPS Actual-0.36-0.16-0.13-0.31
Difference-0.25-0.030.03-0.14
Surprise %-227.30%-23.10%18.80%-82.40%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.160-0.77-0.3
7 Days Ago-0.16-0.07-0.77-0.3
30 Days Ago-0.16-0.07-0.77-0.3
60 Days Ago-0.16-0.07-0.77-0.3
90 Days Ago-0.14-0.07-0.68-0.21
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCGIXIndustrySectorS&P 500
Current Qtr.55.60%N/AN/A-0.01
Next Qtr.N/AN/AN/A0.05
Current Year23.80%N/AN/A0.05
Next Year61.00%N/AN/A0.11
Next 5 Years (per annum)40.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A